Teleflex Incorporated

Valuation Analysis

About the Company

Teleflex Incorporated en bref

Teleflex Incorporated (TFX) is currently trading at 110,79 € with a market capitalization of 4,9 Md €. The trailing P/E ratio stands at 2116x, with a forward P/E of 12.04x. The 52-week range spans from 87,42 € to 121,89 €; the current price is 9.1% below the yearly high. Year-over-year revenue growth stands at +32.3%.

💰 Dividende

Teleflex Incorporated pays an annual dividend of 1,19 € per share, representing a yield of 1.07%. The payout ratio stands at 2266.67%. The elevated payout ratio reflects a mature dividend policy.

📊 Avis des analystes

9 analystes évaluent Teleflex Incorporated (TFX) au consensus : Conserver. L'objectif de cours moyen est de 127,31 €, soit un potentiel de +14.91% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 117,81 € à 139,63 €.

Teleflex Incorporated : la thèse d'investissement en détail

Teleflex Incorporated (TFX) operates in the Healthcare — specifically Medical Instruments & Supplies — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Top-line momentum is unusually strong with revenue expanding 32.3% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind.

Le scénario baissier

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valorisation en contexte

With a PEG ratio of 0.16, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

À surveiller

• The forward P/E of 12.04x is meaningfully below the trailing 2116x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (8.25%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Teleflex Incorporated?

Compare top-rated brokers — low fees, trusted providers, fully regulated.